Search Results - "Roffi, Luigi"

Sustained virologic response prevents the development of esophageal varices in compensated, Child‐Pugh class A hepatitis C virus–induced cirrhosis. A 12‐year prospective follow‐up study by Bruno, Savino, Crosignani, Andrea, Facciotto, Corinna, Rossi, Sonia, Roffi, Luigi, Redaelli, Alessandro, de Franchis, Roberto, Almasio, Piero Luigi, Maisonneuve, Patrick

“…The incidence of de novo development of esophageal varices (EV) in patients with compensated liver cirrhosis has been determined by few studies in the short…”
Get full text

DANTE'S INFERNO, canto XXX: Imaginary or real liver disease? by Roffi, Luigi

Get full text

DANTE 'S INFERNO , canto XXX : Imaginary or real liver disease? by Roffi, Luigi

Get full text

Liver in mythology: A different version of Tityos’ myth by Roffi, Luigi

Get full text

Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients by Sangiovanni, Angelo, Colombo, Edoardo, Radaelli, Franco, Bortoli, Aurora, Bovo, Giorgio, Casiraghi, Maria Antonietta, Ceriani, Roberto, Roffi, Luigi, Redaelli, Alessandro, Rossini, Angelo, Spinzi, GianCarlo, Minoli, Giorgio

“…High hepatocyte proliferation has been recently proposed as a risk factor for the development of hepatocellular carcinoma (HCC). The aim of this study was to…”
Get full text

Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population by Bruno, Savino, Di Marco, Vito, Iavarone, Massimo, Roffi, Luigi, Crosignani, Andrea, Calvaruso, Vincenza, Aghemo, Alessio, Cabibbo, Giuseppe, Viganò, Mauro, Boccaccio, Vincenzo, Craxí, Antonio, Colombo, Massimo, Maisonneuve, Patrick

“…Background & Aims Life expectancy of patients with compensated hepatitis C virus (HCV) cirrhosis achieving sustained virologic response (SVR) is limited by…”
Get full text

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C : Influence of HCV genotype by ROFFI, Luigi, REDAELLI, Alessandro, FORNACIARI, Giovanni, GIUSTI, Massimo, MARIN, Renato, MORALES, Rino, SANGIOVANNI, Angelo, BELLONI, Giovanni, POZZI, Massimo, POLI, Giancarla, MASCOLI, Nerina, CORRADI, Chiara, COLLOREDO, Guido, PIOLTELLI, Pietro, SCALORI, Astrid, MANCIA, Giuseppe, MINOLA, Eliseo, DONADA, Carlo, PICCIOTTO, Antonino, RIBOLI, Paolo, DEL POGGIO, Paolo, RINALDI, Gianni, PARIS, Bruno

“…To assess the influence of hepatitis C virus (HCV) genotypes on the clinical outcome of liver disease, we analysed 2,307 patients. The most frequently…”
Get full text

Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study by Bruno, Savino, Zuin, Massimo, Crosignani, Andrea, Rossi, Sonia, Zadra, Felice, Roffi, Luigi, Borzio, Mauro, Redaelli, Alessandro, Chiesa, Alberto, Silini, Enrico Maria, Almasio, Piero Luigi, Maisonneuve, Patrick

“…The identification of prognostic factors associated with mortality is crucial in any clinical setting. We enrolled in a prospective study 352 patients with…”
Get full text

Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus‐related cirrhosis who attained sustained virological response by Bruno, Savino, Di Marco, Vito, Iavarone, Massimo, Roffi, Luigi, Boccaccio, Vincenzo, Crosignani, Andrea, Cabibbo, Giuseppe, Rossi, Sonia, Calvaruso, Vincenza, Aghemo, Alessio, Giacomelli, Luca, Craxì, Antonio, Colombo, Massimo, Maisonneuve, Patrick

“…Background Few studies examined the outcome of patients with hepatitis C virus (HCV)‐related cirrhosis who developed hepatocellular carcinoma (HCC). The…”
Get full text

Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study by Stroffolini, Tommaso, Almasio, Piero L, Sagnelli, Evangelista, Mele, Alfonso, Gaeta, Giovanni Battista

“…The aim of the study was to evaluate the characteristics of chronic hepatitis B with special reference to the geographical origin of the patients and to the…”
Get full text

Pegylated interferon-α2b plus ribavirin : an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis by ROFFI, Luigi, COLLOREDO, Guido, RAMELLA, Giuliano, CORRADI, Chiara, ROSSINI, Angelo, BRUNO, Savino, PIOLTELLI, Pietro, BELLATI, Giorgio, POZZI, Massimo, PARRAVICINI, Pierpaolo, BELLIA, Valentina, DEL POGGIO, Paolo, FORNACIARI, Giovanni, CERIANI, Roberto

“…Background Little is known about the efficacy, safety and tolerability of pegylated interferon plus ribavirin treatment in patients with chronic hepatitis C…”
Get full text

Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites by Pozzi, M, Carugo, S, Boari, G, Pecci, V, de Ceglia, S, Maggiolini, S, Bolla, G B, Roffi, L, Failla, M, Grassi, G, Giannattasio, C, Mancia, G

“…Cirrhosis is associated with cardiovascular abnormalities. Scanty information is available as to whether these include left ventricle diastolic dysfunction and…”
Get full text

Predicting Mortality Risk in Patients With Compensated HCV-lnduced Cirrhosis : A Long-Term Prospective Study by BRUNO, Savino, ZUIN, Massimo, LUIGI ALMASIO, Piero, MAISONNEUVE, Patrick, CROSIGNANI, Andrea, ROSSI, Sonia, ZADRA, Felice, ROFFI, Luigi, BORZIO, Mauro, REDAELLI, Alessandro, CHIESA, Alberto, SILINI, Enrico Maria

Get full text

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy by SARACCO, Giorgio, OLIVERO, Alda, ROFFI, Luigi, CROCE, Guido, MANCA, Aldo, TAPPERO, Gianfranco, CICCONE, Giovannino, RIZZETTO, Mario, CIANCIO, Alessia, CARENZI, Silvia, SMEDILE, Antonina, CARITI, Giuseppe, ANDREONI, Massimo, ORSI, Pier Giulio, BIGLINO, Alberto, TABONE, Marco

“…To determine whether a higher dosage of interferon (IFN) and/or a prolonged time of administration may improve the efficacy of combination therapy, we…”
Get full text

Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients by Sangiovanni, Angelo, Colombo, Edoardo, Radaelli, Franco, Bortoli, Aurora, Bovo, Giorgio, Casiraghi, Maria Antonietta, Ceriani, Roberto, Roffi, Luigi, Redaelli, Alessandro, Rossini, Angelo, Spinzi, GianCarlo, Minoli, Giorgio

“…OBJECTIVES: High hepatocyte proliferation has been recently proposed as a risk factor for the development of hepatocellular carcinoma (HCC). The aim of this…”
Get full text

A randomized 4-arm multicenter study of interferon alfa–2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone by Saracco, Giorgio, Ciancio, Alessia, Olivero, Alda, Smedile, Antonina, Roffi, Luigi, Croce, Guido, Colletta, Cosimo, Cariti, Giuseppe, Andreoni, Massimo, Biglino, Alberto, Calleri, Guido, Maggi, Giovanni, Tappero, Gian Franco, Orsi, Pier Giulio, Terreni, Natalia, Macor, Antonio, Di Napoli, Angelo, Rinaldi, Enrico, Ciccone, Giovannino, Rizzetto, Mario

“…To determine whether a higher dosage of interferon (IFN) associated with ribavirin and/or prolonged time of administration may improve therapeutic efficacy, we…”
Get full text

Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis by Roffi, Luigi, Colloredo, Guido, Pioltelli, Pietro, Bellati, Giorgio, Pozzpi, Massimo, Parravicini, Pierpaolo, Bellia, Valentina, Del Poggio, Paoolo, Fornaciari, Giovanni, Ceriani, Roberto, Ramella, Giuliano, Corradi, Chiara, Rossini, Angelo, Bruno, Savino

“…Little is known about the efficacy, safety and tolerability of pegylated interferon plus ribavirin treatment in patients with chronic hepatitis Cvirus (HCV)…”
Get full text

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy by Antonelli, G, Simeoni, E, Turriziani, O, Tesoro, R, Redaelli, A, Roffi, L, Antonelli, L, Pistello, M, Dianzani, F

“…MxA, a protein with selective activity against certain viruses, is an accepted specific indicator of type I interferon (IFN) activity. We have developed an…”
Get more information

Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests by Sonzogni, Aurelio, Colloredo, Guido, Fabris, Luca, Cadamuro, Massimiliano, Paris, Bruno, Roffi, Luigi, Pozzi, Massimo, Bovo, Giorgio, Poggio, Paolo Del, Portmann, Bernard C, Strazzabosco, Mario

“…In routine examination of liver biopsies isolated ductular hyperplasia (IDH) may be the only histopathological change. Here we describe the clinical and…”
Get full text

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients by Roffi, Luigi, Ricci, Alessandra, Ogliari, Cristina, Scalori, Astrid, Minola, Eliseo, Colloredo, Guido, Donada, Carlo, Ceriani, Roberto, Rinaldi, Gianni, Paris, Bruno, Fornaciari, Giovanni, Morales, Rino, Del Poggio, Paolo, Sangiovanni, Angelo, Buonocore, Marco, Bellia, Valentina, Riboli, Paolo, Nava, Maria Cristina, Panizzuti, Fabio, Piperno, Alberto, Pozzi, Massimo, Pioltelli, Pietro, Mancia, Giuseppe

“…Background/Aims: Hepatitis C virus (HCV) easily undergoes genomic changes, thus accounting for the presence of different genotypes, with different geographic…”
Get full text